Hemab Therapeutics Holdings, Inc.

COAGCIK 0002114044 · Every Form 4 filed by insiders at this issuer. See financials →

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Most active reporters at Hemab Therapeutics Holdings, Inc.

Name	Roles	Filings
Kolchinsky Peter	Director10% Owner	4
Ra Capital Management, L.P.	Director10% Owner	4
Ra Capital Healthcare Fund LP	Director10% Owner	4
Shah Rajeev M.	Director10% Owner	4
Behrndt-Eriksen Mads Nikolaj	Officer	1

Showing 1-5 of 10

Per pagePage 1 of 2Next

8 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
May 21, 2026	Ra Capital Management, L.P. 10% Owner	PPurchase	3,802	$24.97	$94,936
May 14, 2026	Ra Capital Management, L.P. 10% Owner	PPurchase	6,387	$24.90	$159,036
May 11, 2026	Ra Capital Management, L.P. 10% Owner	PPurchase	25,720	$25.00	$643,000
May 6, 2026	Ra Capital Management, L.P. Director · 10% Owner	PPurchase	2,541,250	$18.00	$45,742,500
May 6, 2026	Novo Holdings A/S 10% Owner	CConversion	4,180,550	-	-

Showing 1-5 of 8

Per pagePage 1 of 2Next

Real-time Form 4 intelligence. Smarter insider tracking.